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A growing body of evidence supports the close relationship between major depressive
disorder (MDD), a severe psychiatric disease more common among women than men,
and alterations of the immune/inflammatory system. However, despite the large number
of studies aimed at understanding the molecular bases of this association, a lack of
information exists on the potential cross-talk between systems known to be involved
in depression and components of the inflammatory response, especially with respect
to sex differences. Brain-derived neurotrophic factor (BDNF) is a neurotrophin with a
well-established role in MDD etiopathology: it is altered in depressed patients as well
as in animal models of the disease and its changes are restored by antidepressant
drugs. Interestingly, this neurotrophin is also involved in the inflammatory response.
Indeed, it can be secreted by microglia, the primary innate immune cells in the central
nervous system whose functions may be in turn regulated by BDNF. With these
premises, in this study, we investigated the reciprocal impact of BDNF and the immune
system by evaluating the neuroinflammatory response in male and female BDNF-
heterozygous mutant mice acutely treated with the cytokine-inducer lipopolysaccharide
(LPS). Specifically, we assessed the potential onset of an LPS-induced sickness
behavior as well as changes of inflammatory mediators in the mouse hippocampus
and frontal cortex, with respect to both genotype and sex. We found that the increased
inflammatory response induced by LPS in the brain of male mice was independent of
the genotype, whereas in the female, it was restricted to the heterozygous mice with
no changes in the wild-type group, suggestive of a role for BDNF in the sex-dependent
effect of the inflammatory challenge. Considering the involvement of both BDNF and
neuroinflammation in several psychiatric diseases and the diverse incidence of such
pathologies in males and females, a deeper investigation of the mechanisms underlying
their interaction may have a critical translational relevance.
Keywords: brain-derived neurotrophic factor, lipopolysaccharide, sex, neuroinflammation, hippocampus
Frontiers in Molecular Neuroscience | www.frontiersin.org 1 July 2019 | Volume 12 | Article 166
fnmol-12-00166 July 16, 2019 Time: 15:44 # 2
Rossetti et al. Neuroinflammatory Response in BDNF+/− Mice
INTRODUCTION
Major depressive disorder (MDD) is a severe psychiatric disease
affecting almost 10% of the general population and estimated
to become the second leading cause of disability by 2020
(Bromet et al., 2011). In addition to the symptom heterogeneity
among patients and to its complex etiology (Otte et al., 2016),
MDD presents a sexually dimorphic nature, characterized by a
twofold greater risk in females to develop the pathology (Brody
et al., 2018; LeGates et al., 2019). On this basis and given
the different immunological response in terms of innate and
adaptive systems among sexes (Klein and Flanagan, 2016), it is
plausible that sex-based differences in immune response might
play an important role to the diverse vulnerability/incidence to
psychiatric disorders (Derry et al., 2015; Rubinow and Schmidt,
2019). In the last years, growing evidence suggests that alterations
in the inflammatory/immune response may contribute to the
susceptibility for different psychiatric conditions, including
MDD (Müller, 2014). Particularly, the increased levels of
peripheral and central inflammatory markers observed in a large
subset of MDD subjects (Raison et al., 2006; Howren et al.,
2009; Dowlati et al., 2010), the high co-morbidity between
MDD and various non-psychiatric illnesses associated with
inflammatory conditions (Anisman, 2008; Berge and Riise, 2015;
Réus et al., 2017), and the development of MDD in a high
percentage of patients under interferon regimen (Raison et al.,
2009; Udina et al., 2012) clearly support the relevance of a
neuroinflammatory component in MDD. In addition, while
changes in immune/inflammatory response have been found in
MDD experimental models based on both the genetic and the
environmental components of the disease (Chourbaji et al., 2011;
Couch et al., 2013; Macchi et al., 2013; Rossetti et al., 2016; Wang
et al., 2018), several studies indicate the immune/inflammatory
system as a potential target for the pharmacological treatment of
MDD (Molteni et al., 2013; Kv et al., 2018; Rossetti et al., 2018a,b;
Lu et al., 2019).
It is known that this complex psychopathology affects
multiple molecular systems such as neurotransmitters,
hormones, and mediators of neuronal plasticity. Among
those, the neurotrophin brain-derived neurotrophic factor
(BDNF) plays a crucial role. Indeed, BDNF levels are reduced
in depressed subjects and the neurotrophin represents a
key step in long-term adaptive changes brought about by
antidepressant drugs (Berton and Nestler, 2006; Martinowich
et al., 2007; Molendijk et al., 2014; Castrén and Kojima, 2017).
In addition, BDNF is dramatically affected by inflammatory
insults (Calabrese et al., 2014; Lima Giacobbo et al., 2018): the
administration of lipopolysaccharide (LPS) or pro-inflammatory
cytokines in rodents has been shown to decrease its levels
in the cortex and hippocampus (Guan and Fang, 2006;
Schnydrig et al., 2007; Patterson, 2015), while the therapeutic
treatment with interferons alters BDNF expression in human
subjects (Capuron et al., 2004; Kenis et al., 2011; Lotrich
et al., 2013). Moreover, microglial cells, the macrophage
resident population within the brain and one of the crucial
components of the neuroinflammatory response, express
BDNF mRNA, secrete the neurotrophin following stimulation,
and are regulated by BDNF signaling (Nakajima et al., 2001;
Ferrini and De Koninck, 2013).
On this basis, the main goal of our study was to investigate
the potential link between neuroinflammation and BDNF in male
and female mice by evaluating if and how the inflammatory
response might be altered in conditions characterized by
compromised expression of the neurotrophin. Accordingly, we
assessed the brain inflammatory response of male and female
BDNF+/− mice, which exhibit an approximately 50% reduction
of BDNF protein and mRNA (Korte et al., 1995; Lyons et al.,
1999; Sairanen et al., 2005; Chourbaji et al., 2012), after an
acute systemic injection of LPS in comparison with wild-
type mice. This experimental setting might actually provide
important information regarding the sex-dependent pathological
consequences of a dysregulated immune/inflammatory response,
pointing out the role of BDNF. In line with our approach, it has
been reported that some biological functions of the neurotrophin
are different in male and female. For instance, the administration
of BDNF may alleviate the pain induced by acetic acid in male rats
but has no effect in females (Li et al., 2010). Moreover, different
basal protein levels of the neurotrophin have been detected in
humans (Hayley et al., 2015) and in rodents (Szapacs et al., 2004;
Franklin and Perrot-Sinal, 2006) as well as a different activation
of the BDNF signaling (Hill and van den Buuse, 2011).
Based on these considerations, we hypothesized that the
altered interaction between the inflammatory system and
BDNF may represent a potential candidate contributing to
the sex-dependent differences in the inflammatory response
that, in turn, might be associated with several psychiatric
disorders such as MDD.
MATERIALS AND METHODS
Animals
Wild-type and BDNF+/− male and female littermate mice
on a C57BL/6N background were bred as described earlier
(Chourbaji et al., 2004). All the animals were housed individually
at the age of 13–19 weeks in standard macrolon cages (type
II—26 cm × 20 cm × 14 cm) with bedding and nesting
material (paper tissue). They were acclimatized at least for
2 weeks to a reserved 12-h dark–light cycle (lights off 8
am to 8 pm) at 22 ± 1◦C room temperature and the
humidity was 35% as described earlier (Chourbaji et al., 2005).
Animals received a standard pellet diet and water ad libitum.
Lastly, to reduce the number of experimental biases, all the
experiments were performed using blind numbers. All animal
experiments were approved by the Animal Welfare Office of the
Regierungspräsidium Karlsruhe, Germany.
LPS Treatment and Behavioral Evaluation
After the acclimatization phase, wild-type and heterozygous mice
were randomly divided to receive saline or LPS (LPS from
Escherichia coli; serotype 026:B6; Sigma Aldrich). The bacterial
toxin was dissolved in sterile, endotoxin-free isotonic saline and
injected i.p. from 1 mg/ml stock solution. We decided to use a
dosage of 400 µg/kg as a low dose of LPS able to induce only
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TABLE 1 | Sequences of forward and reverse primers and probes used in qRT-PCR analyses.
Gene Forward primer Reverse primer Probe
Cd11b∗ CATCCCATGACCTTCCAAGAG GTGCTGTAGTCACACTGGTAG CCACACTCTGTCCAAAGCCTTTTGC
Cx3cl1∗ TCTTCCATTTGTGTACTCTGCT GGACTCCTGGTTTAGCTGATAG TGTCGCACATGATTTCGCATTTCGTC
Cx3cr1∗ GTTATTTGGGCGACATTGTGG ATGTCAGTGATGCTCTTGGG TCTGGTGGGAAATCTGGTTGGTGGTC
β-Actin∗ ACCTTCTACAATGAGCTGCG CTGGATGGCTACGTACATGG TCTGGGTCATCTTTTCACGGTTGGC
Il-1β∗∗ Mm00434228_m1
Il-6∗∗ Mm00446190_m1
Tnf-α∗∗ Mm00443258_m1
Purchased from Eurofins MWG Operon (Germany)∗ and Applied Biosystem (Italy)∗∗.
TABLE 2 | Baseline body weight of the animals used in this study.
Wild type BDNF+/−
Males 28.48 ± 3.26 30.02 ± 3.73
Females 23.34 ± 1.95 25.90 ± 3.45
The body weight was assessed before the beginning of the study. The data are
presented as average weight ± standard deviation of 12 animals/group.
subtle changes in body weight and locomotor activity few hours
from the administration, which disappeared within 24 h (Couch
et al., 2016). In a pilot study, we compared this dosage with
830 µg/kg, which is similar to the amount used in several studies,
finding that the two doses had the same impact on the body
weight and locomotion (data not shown). The lowest dose of
LPS was chosen as it is less aversive to the subjects and in order
to avoid a massive activation of the inflammatory response that
could have masked the molecular impact of the genotype and/or
the sex of the animals. With this experimental design, we obtained
eight groups of animals: wild-type mice treated with saline (male,
n = 5; female, n = 6) or LPS (male, n = 6; female, n = 6); BDNF+/−
mice that received saline (male, n = 6; female, n = 6) or the
bacterial toxin (male, n = 6; female, n = 6).
We assessed body weight before the beginning of the
experiment (baseline), 1 h before LPS administration, and 6
and 24 h after the immune challenge. Moreover, 6 h after the
injection, animals were tested with the Open Field (OF) test
to evaluate alterations in the locomotor activity as previously
reported (Zueger et al., 2005; Richter et al., 2011). Briefly,
after a period of acclimatization to the room (30 min), mice
were individually placed in a square-shaped, white, illuminated
(25 lx) arena, measuring 50 × 50 cm2. The test, conducted
in the active phase of the animals, was monitored from above
for 10 min and recorded by a video camera (Sony CCD
IRIS). For each subject, total distance moved and velocity were
analyzed by a blinded experimenter using the image processing
FIGURE 1 | Evaluation of LPS-induced sickness behavior through body weight and locomotor activity. The body weight of both male (A) and female (B) animals was
measured before LPS injection, 6 and 24 h after the immune challenge. After 6 h from the injection, we tested saline and LPS-treated animals performance with the
OF test to assess the total distance traveled (males, C; females, E) and the velocity (males, D; females, F) as parameters of locomotion.
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FIGURE 2 | Western Blot Analysis of TLR-4 Basal Levels in the Hippocampus and in the Frontal Cortex. The protein levels of the toll like-4 receptor (TLR-4) were
measured in the hippocampus and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice treated with saline.
The data, expressed as a percentage of the saline-injected wild-type mice (CTRL, set at 100%), represent the mean ± SEM of at least five independent
determinations.
system Etho Vision 3.0 (Noldus Information Technology).
Animals were sacrificed 24 h after LPS injection, the brains
were harvested, and the hippocampus and frontal cortex were
dissected on ice from both the hemispheres. The tissues were
rapidly frozen on dry ice and stored at −80◦C until the
molecular analyses.
RNA Preparation and Gene Expression
Analyses
For gene expression analyses, total RNA was isolated from
the different brain regions by single-step guanidinium
isothiocyanate/phenol extraction using PureZol RNA
isolation reagent (Bio-Rad Laboratories S.r.l.) according
to the manufacturer’s instructions and quantified by
spectrophotometric analysis. The samples were then processed
for real-time polymerase chain reaction (PCR) as previously
reported (Rossetti et al., 2016) to assess mRNA levels
of target genes.
Briefly, an aliquot of each sample was treated with DNase
to avoid DNA contamination and subsequently analyzed by
TaqMan qRT-PCR instrument (CFX384 real-time system, Bio-
Rad Laboratories S.r.l.) using the iScript one-step RT-PCR kit for
probes (Bio-Rad Laboratories S.r.l). Samples were run in 384-well
format in triplicate as multiplexed reactions with a normalizing
internal control (β-Actin). Thermal cycling was initiated with
incubation at 50◦C for 10 min (RNA retrotranscription), and
then at 95◦C for 5 min (TaqMan polymerase activation). After
this initial step, 39 cycles of PCR were performed. Each PCR
cycle consisted of heating the samples at 95◦C for 10 s to
enable the melting process and then for 30 s at 60◦C for
the annealing and extension reactions. A comparative cycle
threshold (Ct) method was used to calculate the relative
target gene expression. Probe and primer sequences used
were purchased from Applied Biosystem Italia and Eurofins
MWG-Operon. A complete list of primers and probes is
presented in Table 1.
Protein Extraction and Western Blot
Analysis
Protein extracts were obtained as previously described
(Rossetti et al., 2018a,b). Briefly, brain samples were manually
homogenized using a glass–glass potter in a pH 7.4 cold isotonic
buffer and then sonicated for 10 s at a maximum power of
10–15% (Bandelin Sonoplus). The homogenate was clarified
by centrifugation to obtain a pellet (P1) enriched in nuclear
components, which was resuspended in a hypotonic buffer. The
supernatant (S1) was then centrifuged (13,000 × g; 15 min)
to obtain a clarified fraction of cytosolic proteins (S2). The
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FIGURE 3 | Gene expression analysis of IL-1β in the hippocampus and in the frontal cortex. The mRNA levels of the pro-inflammatory cytokine IL-1β were measured
in the hippocampus and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice 24 h after a single injection of
lipopolysaccharide (LPS, 400 µg/kg i.p). in comparison with mice treated with saline. The data, expressed as a percentage of the saline-injected wild-type mice
(CTRL, set at 100%), represent the mean ± SEM of at least six independent determinations. ∗∗∗P < 0.001 vs. CTRL; ###P < 0.001 vs. BDNF+/−; ++P < 0.01 vs.
WT/LPS (Two-way ANOVA with PLSD).
pellet (P2), corresponding to the crude membrane fraction,
was resuspended in the same buffer used for the nuclear
fraction. Total protein content was measured according to
the Bradford Protein Assay procedure (Bio-Rad Laboratories),
using bovine serum albumin as calibration standard. For the
protein analysis, 10 µg of P2 protein lysates were run under
reducing conditions on polyacrylamide gels and then transferred
onto nitrocellulose membranes. Unspecific binding sites were
blocked with 10% non-fat dry milk and then the membranes
were incubated overnight with the primary antibody (TLR-4
Santa Cruz cat. sc-10741; 1:1,000), followed by a 1-h incubation
at room temperature with a peroxidase-conjugated anti-rabbit
IgG. Immunocomplexes were visualized by chemiluminescence
using the ETA C2.0 (Cyanagen). Protein levels were calculated
by measuring the optical density of the immunocomplexes using
chemiluminescence (Chemidoc MP Imaging System, Bio-Rad
Laboratories) and results were standardized on β-Actin (Sigma
cat. A5441; 1:10000) bands at 43 kDa as internal control.
Statistical Analyses
Behavioral data were analyzed using repeated measurement
ANOVA (Time∗LPS∗Genotype): one-way ANOVA
(Treatment) or two-way ANOVA (LPS∗Genotype). When
appropriate, Bonferroni post hoc tests were used to evaluate
furtherdifferences between groups.
Molecular data were analyzed by two-way ANOVA, with
treatment (Saline vs. LPS) or genotype (wild type vs. BDNF+/−)
as independent factors. When appropriate, direct contrasts
were analyzed with Fisher’s protected least significant difference
(PLSD). All the molecular analyses were carried out in individual
animals (independent determinations), and for graphic clarity,
data are presented as mean percent ± standard error (SEM) of
control group, with significance threshold set at P < 0.05.
RESULTS
LPS Administration Alters the Body
Weight and the Locomotion of Both Male
and Female Animals
First, we have assessed the ability of LPS to induce the so-
called sickness behavior by measuring the body weight of the
animals and monitoring their locomotor activity in the OF test
6 h after the inflammatory challenge. Although it is known
from the literature that at this time point LPS may cause
behavioral consequences, our aim was to evaluate the influence
of sex or genotype.
At baseline, wild-type and heterozygous mice showed
differences in body weight that were statistically significant only
in female animals as a result of the BDNF partial deletion
(Genotype: F1,20 = 6.940, P < 0.05; Table 2 and Figures 1A,B).
After LPS administration, we observed a decrease of body weight
over time in male (LPS∗Time, F1,19 = 17.046, P < 0.001;
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FIGURE 4 | Gene expression analysis of TNF-α in the hippocampus and in the frontal cortex. The mRNA levels of the pro-inflammatory cytokine TNF-α were
measured in the hippocampus and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice 24 h after a single
injection of lipopolysaccharide (LPS, 400 µg/kg i.p). in comparison with mice treated with saline. The data, expressed as a percentage of the saline-injected
wild-type mice (CTRL, set at 100%), represent the mean ± SEM of at least six independent determinations. ∗∗∗P < 0.001 vs. CTRL; ###P < 0.01 vs. BDNF+/−;
++P < 0.01 vs. WT/LPS (Two-way ANOVA with PLSD).
Figure 1A), while in female mice, the impact of the immune
challenge was blunted by the basal genotype effect (Figure 1B).
In the OF test, we analyzed the total distance moved and the
velocity of the animals 6 h after the exposure to the bacterial toxin.
As shown in Figure 1C, the total distance moved by male mice
treated with LPS was reduced when compared to the locomotion
of saline-treated mice (LPS, F1,23 = 74.485, P< 0.001; Figure 1C)
irrespective of the genotype. A similar, but milder effect was
observed for female animals; indeed, LPS treatment significantly
affected the distance traveled (F1,20 = 7.566, P < 0.05; Figure 1E)
in both wild-type and heterozygous mice.
LPS also modulated the velocity of the animals during the
locomotion test, which was reduced in both male (F1,19 = 73.859,
P < 0.001; Figure 1D) and female mice (F1,20 = 7,582, P < 0.05;
Figure 1F) without any effect of the genotype. Similar to what was
previously observed, the magnitude of the LPS-induced changes
was higher in male animals.
Wild-Type and Heterozygous Mice Have
the Same Basal Levels of TLR-4, Without
Gender Differences
To exclude the idea that LPS could have acted on a different
receptor background, we examined the protein levels of toll-
like receptor 4 (TLR-4), the endogenous receptor for the
bacterial toxin.
As shown in Figure 2, we did not find any difference among
the experimental groups.
The Immune Challenge Differentially
Affects the Cytokine Expression Profile
in the Hippocampus and Frontal Cortex
of Male and Female Heterozygous Mice
Next, we investigated if sex or genotype may also influence also
the molecular impact of the inflammatory challenge. With this
aim, we analyzed the gene expression of the pro-inflammatory
cytokines IL-1β, TNF-α, and IL-6 in the hippocampus and
in the frontal cortex of wild-type and mutant mice of both
sexes. The molecular analyses were performed 24 h after the
immune challenge to avoid the peak of cytokine expression
usually observed in the first hours from LPS injection, which
could confound the influence of the other two variables.
IL-1β gene expression was significantly modulated by LPS
administration in the hippocampus of both wild-type and
heterozygous male mice (F1,19 = 179.8, P < 0.001). Specifically,
the challenge markedly increased the pro-inflammatory cytokine
without differences between the two genotypes (WT/LPS
+465% vs. WT/SAL, P < 0.001; BDNF+/−/LPS +571% vs.
BDNF+/−/SAL, P < 0.001; Figure 3A). Conversely, a different
profile was observed in the hippocampus of female mice where
the significant effect of the LPS injection (F1,18 = 14.17,
P < 0.01) was restricted to the mutant animals, as indicated
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FIGURE 5 | Gene expression analysis of IL-6 in the hippocampus and in the frontal cortex. The mRNA levels of the pro-inflammatory cytokine IL-6 were measured in
the hippocampus and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice 24 h after a single injection of
lipopolysaccharide (LPS, 400 µg/kg i.p). in comparison with mice treated with saline. The data, expressed as a percentage of the saline-injected wild-type mice
(CTRL, set at 100%), represent the mean ± SEM of at least six independent determinations. ∗∗∗P < 0.001 vs. CTRL; ###P < 0.001 vs. BDNF+/− (Two-way ANOVA
with PLSD).
by the significant treatment∗genotype interaction (F1,18 = 10.85,
P < 0.01). Indeed, as shown in Figure 3, IL-1β mRNA levels
were significantly induced by LPS only in the heterozygous mice
(BDNF+/−/LPS +324% vs. BDNF+/−/SAL, P < 0.001; +262%
vs. WT/LPS, P < 0.01; Figure 3B) with no changes in wild-type
animals. Moreover, it has to be noted that the magnitude of the
cytokine induction in female mice was lower with respect to male
animals, although its basal expression was similar.
In the frontal cortex of male mice, IL-1β expression
was similar to that observed in the hippocampus. LPS
administration, indeed, significantly increased the mRNA of
the pro-inflammatory cytokine (F1,22 = 45.49, P < 0.001) in
both wild-type (WT/LPS +309% vs. WT/SAL, P < 0.001)
and heterozygous male mice (BDNF+/−/LPS +324% vs.
BDNF+/−/SAL, P < 0.001; Figure 3C) without differences
between the two experimental groups. Conversely, no changes
in IL-1β levels were found in the frontal cortex of female mice
exposed to LPS (Figure 3D).
Similarly to what was observed for IL-1β, the mRNA levels
of TNF-α were significantly up-regulated by the LPS treatment
in male mice (F1,20 = 42.58, P < 0.001), an effect independent
of the genotype. In fact, the inflammatory challenge strongly
induced the expression of TNF-α in the hippocampus in
both wild-type (WT/LPS +1287% vs. WT/SAL, P < 0.001;
Figure 4A) and mutant mice (BDNF+/−/LPS +1142% vs.
BDNF+/−/SAL, P < 0.001; Figure 4A) without any significant
difference between the genotypes. On the contrary, in female
mice, the increased TNF-α gene expression by LPS was limited
to the mutant animals, as indicated by the significant effects
of LPS (F1,18 = 6.74, P < 0.05), genotype (F1,18 = 10.7,
P < 0.01), and interaction between LPS∗Genotype (F1,18 = 4.95,
P < 0.05). Again, this increase was less pronounced with respect
to the modulations observed in male mice (BDNF+/−/LPS
+186% vs. BDNF+/−/SAL, P < 0.01; +164% vs. WT/LPS
∗∗P < 0.01; Figure 4B).
In the frontal cortex, the gene expression profile of TNF-α was
qualitatively comparable to that observed in the hippocampus,
although the effect of the inflammatory challenge was lower.
As shown in Figure 4C, we found a significant increase
of TNF-α mRNA levels after LPS injection (F1,22 = 42.43,
P < 0.001) in both wild-type (WT/LPS +544% vs. WT/SAL,
P < 0.001) and mutant male mice (BDNF+/−/LPS +678% vs.
BDNF+/−/SAL, P < 0.001). Interestingly, a slight but significant
modulation of TNF-α by LPS (F1,21 = 4.45, P = 0.05) was also
observed in heterozygous female mice (BDNF+/−/LPS+55% vs.
BDNF+/−/SAL, P < 0.01; Figure 4D).
The expression of IL-6 was differentially modulated by LPS
administration if compared to the other cytokines. Indeed, the
inflammatory challenge significantly decreased IL-6 mRNA levels
(F1,19 = 42.84, P < 0.001) in both wild-type (WT/LPS -56% vs.
WT/SAL, P < 0.001) and heterozygous mice (BDNF+/−/LPS
-65% vs. BDNF+/−/SAL, P < 0.001; Figure 5A). On the
contrary, we did not observe any significant change in female
mice (Figure 5B).
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 July 2019 | Volume 12 | Article 166
fnmol-12-00166 July 16, 2019 Time: 15:44 # 8
Rossetti et al. Neuroinflammatory Response in BDNF+/− Mice
FIGURE 6 | Gene expression analysis of CD11b in the hippocampus and in the frontal cortex. The mRNA levels of the microglial marker CD11b were measured in
the hippocampus and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice 24 h after a single injection of
lipopolysaccharide (LPS, 400 µg/kg i.p). in comparison with mice treated with saline. The data, expressed as a percentage of the saline-injected wild-type mice
(CTRL, set at 100%), represent the mean ± SEM of at least six independent determinations. ∗P < 0.05 vs. CTRL; ###P < 0.001 vs. BDNF+/−/LPS; ++P < 0.01 vs.
WT/LPS (two-way ANOVA with PLSD).
In line with the observed expression profile in the
hippocampus, the expression of IL-6 was significantly down-
regulated by LPS also in the frontal cortex of male mice
(F1,19 = 123.9, P < 0.001). The impact of the immune challenge
altered the expression of the cytokine in wild-type (WT/LPS
-77% vs. WT/SAL, P < 0.001) as well as mutant animals
(BDNF+/−/LPS -66% vs. BDNF+/−/SAL, P< 0.001; Figure 5C),
an effect even greater in this brain region, when compared to
the hippocampus. IL-6 expression was not affected in the frontal
cortex of female mice (Figure 5D).
LPS Administration Differentially
Modulates Microglial Markers in Male
and Female Brain, With a Specific
Influence of the Genotype
Considering the pivotal role of microglia in the immune response
within the central nervous system, we analyzed the expression
of a marker of microglia activation, namely, CD11b, and two
molecules involved in the control of microglia response, such as
fractalkine (CX3CL1) and its receptor (CX3CR1).
The analyses on the hippocampus of male mice indicated
that the expression of CD11b was significantly modulated
by the inflammatory challenge (F1,23 = 48.93, P < 0.001)
and by the genotype (F1,23 = 5.05, P < 0.05). As shown
in Figure 6A, CD11b expression was increased in both
wild-type (WT/LPS +27% vs. WT/SAL, P < 0.01) and
BDNF heterozygous mice (BDNF+/−/LPS +60% vs.
BDNF+/−/SAL, P < 0.001). Interestingly, this effect was
significantly higher in the mutant animals (BDNF+/−/LPS
+31% vs. WT/LPS, P < 0.01) as indicated by the
LPS∗Genotype interaction (F1,23 = 6.85, P < 0.05). In
the hippocampus of female mice, the expression of the
microglial marker was significantly affected by the immune
challenge (F1,23 = 13.06, P < 0.01) only in mutant animals
(BDNF+/−/LPS +44% vs. BDNF+/−/SAL, P < 0.001;
Figure 6B). Conversely, in the frontal cortex, we did not
observe any significant modulation of the expression of CD11b
by LPS or by the genotype, neither in male nor in female
mice (Figures 6C,D).
The gene expression analyses of fractalkine in the
hippocampus of male mice indicated a significant impact
of the genotype (F1,22 = 8.72, P < 0.01). Indeed, the basal
levels of CX3CL1 were significantly higher only in BDNF
heterozygous mice if compared to control mice (BDNF+/−/SAL
+36% vs. WT/SAL, P < 0.01; Figure 7A). Conversely, the
mRNA levels of CX3CL1 in female mice were modulated
by LPS administration (F1,23 = 5.07, P < 0.05) only in
wild-type animals (WT/LPS -16% vs. WT/SAL, P < 0.05;
Figure 7B). No significant changes were found in the prefrontal
cortex (Figures 7C,D).
Despite the slight modulation of fractalkine observed
in the hippocampus of male mice, the inflammatory
challenge had significant effect on CX3CR1 (F1,22 = 34.17,
Frontiers in Molecular Neuroscience | www.frontiersin.org 8 July 2019 | Volume 12 | Article 166
fnmol-12-00166 July 16, 2019 Time: 15:44 # 9
Rossetti et al. Neuroinflammatory Response in BDNF+/− Mice
FIGURE 7 | Gene expression analysis of CX3CL1 in the hippocampus and in the frontal cortex. The mRNA levels of CX3CL1 were measured in the hippocampus
and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice 24 h after a single injection of lipopolysaccharide
(LPS, 400 µg/kg i.p). in comparison with mice treated with saline. The data, expressed as a percentage of the saline-injected wild-type mice (CTRL, set at 100%),
represent the mean ± SEM of at least six independent determinations. ∗P < 0.05 and ∗∗P < 0.01 vs. CTRL (two-way ANOVA with PLSD).
P < 0.001). Specifically, the mRNA levels of the receptor
were significantly increased by LPS in both wild-type
(WT/LPS +50% vs. WT/SAL, P < 0.001; Figure 8A)
and BDNF heterozygous mice (BDNF+/−/LPS +45% vs.
BDNF+/−/SAL, P < 0.001; Figure 8A). In female mice,
the hippocampal CX3CR1 expression was up-regulated
following the treatment (F1,24 = 5.54, P < 0.05), but only
in heterozygous mice (BDNF+/−/LPS+22% vs. BDNF+/−/SAL,
P < 0.05; Figure 8B).
Although we observed a similar modulation also in the frontal
cortex of male (Figure 8C) and female mice (Figure 8D), neither
the impact of the immune challenge nor the BDNF mutation
significantly affected the expression of fractalkine receptor.
DISCUSSION
In this study, we show that the partial deletion of BDNF
influences the inflammatory response to LPS in a sex-specific
manner. Specifically, we found that the molecular impact
of the inflammatory challenge was different in the two
sexes: high in male mice independently from the genotype,
almost null in wild-type female mice, and mild in the
BDNF heterozygous female mice. This effect was mainly
observed in the hippocampus, suggesting a pivotal role for
the neurotrophin in the inflammatory response of this area of
the female brain.
The systemic injection of LPS in the rodent mimics
a gram-negative bacterial infection that induces a massive
inflammatory response with a release of pro-inflammatory
cytokines and the insurgence of the so-called “sickness behavior,”
characterized by decreased motor activity, social withdrawal,
reduced food and water intake, and altered cognition within
a few hours from the LPS administration (Dantzer et al.,
2008). Likewise, we found reduced body weight and decreased
locomotor activity 6 h after the LPS administration, an
effect independent from genotype but influenced by sex. It
is important to mention that animals of both sexes were
single caged. While single housing could have been more
favorable for male mice due to less social distress and aggressive
behaviors (Chourbaji et al., 2005; Kamakura et al., 2016;
Kappel et al., 2017), individual housing could have affected the
behavior of female mice. Nevertheless, the baseline levels of
the parameters analyzed in the OF were comparably similar
between sexes, suggesting that the housing condition apparently
did not alter the behavioral outcomes analyzed in our study.
Male mice showed a stronger induction of sickness behavior
if compared to the female counterpart, as indicated by a
greater weight loss and a worse OF performance, in line
with previous published data (Cai et al., 2016). Similarly,
the neuroinflammatory response was stronger in males than
in females when assessed at molecular levels. Thus, the
mRNA levels of IL-1β and TNF-α were increased in the
hippocampus and frontal cortex of male mice but not in
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 July 2019 | Volume 12 | Article 166
fnmol-12-00166 July 16, 2019 Time: 15:44 # 10
Rossetti et al. Neuroinflammatory Response in BDNF+/− Mice
FIGURE 8 | Gene expression analysis of CX3CR1 in the hippocampus and in the frontal cortex. The mRNA levels of CX3CR1 were measured in the hippocampus
and in the frontal cortex of male (A,C) and female (B,D) wild-type (WT) and BDNF heterozygous (BDNF+/−) mice 24 h after a single injection of lipopolysaccharide
(LPS, 400 µg/kg i.p). in comparison with mice treated with saline. The data, expressed as a percentage of the saline-injected wild-type mice (CTRL, set at 100%),
represent the mean ± SEM of at least six independent determinations. ∗∗∗P < 0.001 vs. CTRL; #P < 0.05 and ###P < 0.001 vs. BDNF+/− mice (two-way ANOVA
with PLSD).
females. These changes were paralleled by a strong decrease
of IL-6 transcripts in male mice 24 h after LPS, an effect
that was already reported in other studies (Schneiders et al.,
2015) and could probably be ascribed to the inhibitory activity
of the suppressor of cytokine signaling 3 (SOCS3), a protein
controlling the negative feedback regulation of IL-6 (Babon
et al., 2014). Since it has been shown that TNF-α is able to
induce SOCS3 protein levels, thus modulating IL-6 pathway
(Dagvadorj et al., 2010), the cross-talk between these two
cytokines might explain the decrease of IL-6 observed only
in the brain of male mice where the levels of TNF-α were
dramatically increased.
It has to be noted that, despite the observed sex-dependent
differences in LPS response, the toxin is acting on the same
receptor background, as no basal changes in the expression of
TLR-4, the endogenous receptor for LPS, were observed in any
experimental group.
The differences in the inflammatory response among
the sexes are actually well known (Klein and Flanagan,
2016); however, beside a role for genetic and/or hormonal
mediators, a lack of information exists regarding the
underlying mechanisms.
Among the molecular systems that might contribute to
such differential response, our data suggest a role for the
neurotrophin BDNF. Indeed, the BDNF+/− female mice showed
a significant LPS-dependent increase of the abovementioned
cytokines, mainly in the hippocampus, an effect that—to
our knowledge—has never been reported. To further analyze
the different expression profile between male and female
heterozygous mice, we focused our attention on microglia,
the immune resident cell population of the brain. In addition
to their role as first-line immune defense within the CNS,
these cells are involved in several mechanisms of neuronal
homeostasis such as neural plasticity, synaptic remodeling
and architecture, neurogenesis, and apoptosis (Paolicelli et al.,
2011; Tay et al., 2018). As a consequence, their abnormal
activation may impact key processes contributing to the
pathophysiology of several diseases. In our study, the mRNA
levels of CD11b, a marker of microglia activation, were
increased after LPS in the hippocampus of male mice of
both genotypes, with an expression profile comparable to that
observed for the inflammatory cytokines IL-1β and TNF-α.
Interestingly, only heterozygous female mice showed increased
hippocampal levels of CD11b, a result that enlightens the
enhanced susceptibility of mutant females. To confirm this
modulation, we also analyzed the expression of fractalkine
(CX3CL1) and its receptor (CX3CR1). CX3CL1 is mainly
produced by neurons to bind its receptor on microglia surface, in
order to control its activation state (Biber et al., 2007; Paolicelli
et al., 2014). Interestingly, while fractalkine did not show
clear modulations, CX3CR1 followed the expression profile of
CD11b, in light of the specific expression of fractalkine receptor
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in this cellular population (Wolf et al., 2013). Accordingly, a
different activation of microglia may contribute to the sex-
dependent effect of LPS. Microglia cells show sex differences
from the developmental stages in the rodent fetal brain: while
males have more microglia in the developing brain, females
boost the number of activated microglia during adulthood (Lenz
and McCarthy, 2015). Moreover, adult microglia present several
differences between males and females in terms of morphology,
function, and transcriptional signature (Bilbo, 2017; Hanamsagar
et al., 2017; Guneykaya et al., 2018). Our findings provide
new information showing that BDNF may differently influence
the microglia response in males and females, supporting the
capability of the neurotrophin to act also at the immune
level. In this sense, Lai et al. (2018) recently demonstrated
that BDNF participates in the modulation of inflammatory
homeostasis, with an anti-inflammatory activity on microglia
through the erythropoietin (EPO) and sonic hedgehog (Shh)
signaling pathways. Moreover, BDNF is also able to modulate
the internal Ca2+ influx in microglia cells, thus controlling the
release of pro-inflammatory molecules from activated microglia.
These functions would suggest that BDNF might have—in the
female—an anti-inflammatory impact through the control of
microglial activation (Mizoguchi et al., 2009). Accordingly, the
molecular susceptibility of heterozygous females to the LPS
administration might be a potential consequence of differences
in BDNF activity among the sexes. Interestingly, it has been
shown that basal BDNF protein levels are doubled in females
compared to males (Chourbaji et al., 2012), a finding that could
be associated to the “masculinized” inflammatory response of
female mutant mice lacking the neurotrophin. This observation
supports the idea of a sex-dependent mechanism of action
of the neurotrophin (Chan and Ye, 2017). In this sense, sex
hormones might play a pivotal role in the control of BDNF
expression. First, given that the BDNF gene contains an estrogen
responsive element, the higher levels of circulating estrogens
in females may control its expression with a transcriptional
mechanism (Sohrabji et al., 1995). A caveat of our study is
that we did not examine the estrous cycle of the female mice
when LPS was administered. Further studies will be necessary
to investigate the interaction between estrogens and BDNF in
an inflammatory context, specifically taking into consideration
the reported protective anti-inflammatory activity of these
hormones (Vegeto et al., 2008; Villa et al., 2015). On the
other hand, testosterone—whose levels are higher in males—
can be converted into estrogen in specific brain regions by
the enzyme aromatase, thus modulating BDNF expression with
an estrogen-mediated mechanism also in males (Wei et al.,
2017). Therefore, considering the sexual dimorphism of estrogen
receptor and aromatase (Wu et al., 2009), BDNF transcription
might be controlled with a sex-specific mechanism. Interestingly,
not only the expression per se, but also the activation of the
BDNF signaling differs from males to females. Specifically,
Hill and co-workers demonstrated that male BDNF+/− mice
have increased activation of the cognate receptor of the
neurotrophin, tropomyosin receptor kinase B (TrkB), when
compared to female mutant mice. Despite the fact that the
mechanism responsible for this increase has not been clarified,
the authors suggest a potential contribution of steroid hormones
(Hill and van den Buuse, 2011). This observation could, at
least in part, explain the increased susceptibility in female
mice in our study, since a basal increased TrkB activity
in male mice could compensate for the lack of BDNF due
to the mutation.
Based on the involvement of the immune/inflammatory
system in the different vulnerability of the male and female brain
to develop neurological and psychiatric disorders (Zagni et al.,
2016), our results reveal a sex-dependent activity of BDNF on
neuroinflammation suggestive of a potential new role for the
neurotrophin in the sexual dimorphism of the central nervous
system. Although the underlying molecular mechanism is still
unknown, this finding might be of great interest for future
studies aimed at developing therapeutic strategies for brain
disorders with higher prevalence in women, in which BDNF
plays a key role.
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